The FDA has approved an oral, small molecule MEK inhibitor for adult and pediatric patients 2 years of age and older with ...
Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a national pharmacy partner by ...
Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...
Achieved $61.5 million and $172.0 million in fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively ...
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
Stamford, Connecticut-based SpringWorks' Gomekli (mirdametinib ... in patients with the genetic disorder neurofibromatosis type 1 (NF1), a rare genetic condition. NFI causes tumours to develop ...
4don MSN
“Cupid’s Undie Run” is held annually and raises money for Neurofibromatosis, a genetic disorder that causes tumors to grow on ...
18h
Stocktwits on MSNSpringWorks Therapeutics Gains Retail Interest Ahead Of Q4 Earnings – What Investors ExpectSpringWorks Therapeutics Inc. (SWTX) shares surged more than 10% in Wednesday’s after-hours, signaling strong investor ...
PITTSBURGH — Hundreds of people braved the cold weather and rain in just their underwear for a fundraiser in Pittsburgh. “Cupid’s Undie Run” is held annually and raises money for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results